DCF — SAMARITAN MEDICAL CENTER
Enterprise Value: $-292.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-292.7M
Enterprise Value
$-96.0M
PV of Cash Flows
$-196.6M
PV of Terminal Value
$-316.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $285.5M | $-16.4M | -6.0% | $-28.4M | $-25.9M |
| Year 2 | $294.0M | $-13.9M | -5.0% | $-26.4M | $-21.8M |
| Year 3 | $302.9M | $-11.3M | -4.0% | $-24.1M | $-18.1M |
| Year 4 | $312.0M | $-10.1M | -3.0% | $-23.3M | $-15.9M |
| Year 5 | $321.3M | $-9.6M | -3.0% | $-23.2M | $-14.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-292.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$277.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.06228864088139358
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5